Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 15, 2026

SPDR S&P Semiconductor ETF (XSD) Climbs +17% in 30 Days: Unpacking the Semiconductor Rally

Key Takeaways

  • XSD surged +17% over the past 30 days, driven by robust demand for semiconductors fueled by artificial intelligence (AI) applications and strong performances from top holdings like Marvell Technology (MRVL) and Astera Labs.
  • Over the past quarter, the ETF gained +11%, reflecting broader sector recovery amid AI infrastructure buildout despite some macroeconomic volatility.
  • Equal-weighted structure benefited from smaller semiconductor firms' outperformance, amplifying gains from AI-related chip demand.
  • Positive fund inflows boosted assets under management (AUM) to nearly $2 billion, signaling investor confidence in the sector.
  • Key macro trends like anticipated interest rate cuts supported high-growth tech exposure in XSD.

Overview of the SPDR S&P Semiconductor ETF (XSD) and Its Portfolio

The SPDR S&P Semiconductor ETF (XSD), managed by State Street Global Advisors, tracks the S&P Semiconductor Select Industry Index. This equal-weighted benchmark focuses exclusively on the U.S. semiconductor sub-industry within the broader S&P Total Market Index, providing targeted exposure to companies involved in semiconductor design, manufacturing, and distribution.

In my view, XSD holds approximately 44 stocks, with no single position exceeding 3.5% due to its equal-weighting methodology. Top holdings include Marvell Technology Inc. (MRVL) at 3.47%, Credo Technology Group Holding Ltd. at 3.23%, Astera Labs Inc. at 3.21%, Intel Corporation (INTC) at 3.12%, and Rambus Inc. at 3.08%. The portfolio is 100% allocated to the technology sector, specifically semiconductors, making it highly sensitive to chip demand cycles, particularly in AI and data centers. This concentrated exposure explains XSD's amplified reactions to sector-specific news and trends, contributing to its recent upward price movement.

XSD Price Performance: 30 Days Versus the Quarter

Over the last 30 days, XSD rose from a close of $333.46 on March 16, 2026, to $389.06 on April 14, 2026, marking a +17% gain. The movement was trend-driven with steady upward momentum, accelerating in early April amid sector tailwinds. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the strength of the uptrend.

For the past quarter, the ETF advanced +11% from $351.84 on January 15, 2026, to the recent $389.06 close. Performance was volatile but net positive, with a recovery from mid-quarter dips to new highs, reflecting resilient sector dynamics.

Drivers Behind XSD's +17% Gain in the Last 30 Days

The semiconductor sector's rally, propelled by surging AI infrastructure demand, was the primary catalyst for XSD's +17% advance. Companies like Nvidia have spotlighted AI chip needs, benefiting equal-weighted peers in XSD through spillover enthusiasm. Top holdings shone: Marvell Technology (MRVL), a key data center chip provider, and Astera Labs, focused on AI connectivity solutions, posted strong gains, each contributing meaningfully given their ~3% weights.

One thing that stands out is how broader sector performance, with AI-driven optimism overriding concerns over supply chain issues, lifted smaller-cap semis disproportionately in XSD's portfolio. Positive fund flows, evidenced by AUM growth to $1.93 billion, reinforced the uptrend as investors piled into thematic tech exposure. Market sentiment shifted favorably on expectations of softer interest rates, aiding growth-oriented holdings.

Factors Driving XSD's +11% Quarterly Performance

XSD's +11% quarterly gain stemmed from sustained AI adoption and semiconductor supply chain stabilization. Early-quarter volatility from macroeconomic data and interest rate uncertainty pressured prices, but mid-quarter AI hype—fueled by hyperscaler capex announcements—sparked a rebound. Major holdings like Intel (INTC), undergoing manufacturing expansions, and Monolithic Power Systems (MPWR) benefited from enterprise AI shifts.

Institutional inflows into semiconductor ETFs, including XSD, supported AUM expansion amid broader market cycles favoring tech. From what I see, cumulative impacts from rising data center builds and edge computing trends outweighed headwinds like potential trade tensions, driving the net positive return.

AI Screener

I rely on Tickeron’s AI Screener as part of my routine analysis—it's an AI-powered stock and ETF discovery tool that helps me filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. I use it to scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions across sectors like semiconductors.

XSD Outlook: What to Watch Next

I'm watching the semiconductor sector outlook closely for XSD, particularly AI capital expenditures from tech giants and supply-demand balances for advanced chips. Key macro factors include Federal Reserve interest rate decisions, inflation trends, and U.S.-China trade relations impacting global supply chains. Performance of major holdings like MRVL and INTC will remain critical, alongside industry trends in edge AI and automotive semiconductors. Potential risks involve cyclical downturns or geopolitical tensions, while catalysts could emerge from earnings beats or new AI applications.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: XSD

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


XSD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for XSD turned positive on September 08, 2026. Looking at past instances where XSD's MACD turned positive, the stock continued to rise in 47 of 52 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on XSD as a result. In 75 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

XSD moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XSD crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +4.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where XSD advanced for three days, in 295 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

The Aroon Indicator entered an Uptrend today. In 297 of 313 cases where XSD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for XSD moved out of overbought territory on October 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 40 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XSD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

XSD broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI), NXP Semiconductors NV (NASDAQ:NXPI).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the semiconductor segment of a U.S. total market composite index. In seeking to track the performance of the S&P Semiconductor Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the semiconductors segment of the S&P Total Market Index ("S&P TMI").

Market Cap

The average market capitalization across the State Street SPDR S&P Semiconductor ETF (XSD) ETF is 261.96B. The market cap for tickers in the group ranges from 441.47M to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is MRAM at 441.47M.

High and low price notable news

The average weekly price growth across all stocks in the State Street SPDR S&P Semiconductor ETF (XSD) ETF was 5%. For the same ETF, the average monthly price growth was 12%, and the average quarterly price growth was 54%. WOLF experienced the highest price growth at 22%, while CBRS experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the State Street SPDR S&P Semiconductor ETF (XSD) ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was -62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 70
P/E Growth Rating: 50
Price Growth Rating: 38
SMR Rating: 67
Profit Risk Rating: 66
Seasonality Score: 32 (-100 ... +100)
View a ticker or compare two or three
XSD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Technology

Category
Technology
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.